On the recordJanuary 29, 2015
Mr. President, I am pleased to talk about an issue that as Senator Alexander said is near and dear to my heart; that is, ensuring that America's patients have access to the most cutting-edge medical products in as timely a manner as possible. I look forward to the partnership that Chairman Alexander and I have in what I think is one of the most crucial studies and processes we will go through in this session of Congress. Many of my colleagues know that holding the National Institutes of Health and the Food and Drug Administration accountable for their work on behalf of America's patients is not a new area of focus for either one of us. After I was first elected to serve in the House of Representatives, I was tasked with modernizing the Food and Drug Administration, a Federal agency that controls 25 cents of every $1 of our economy. This work culminated in the Food and Drug Administration Modernization Act of 1977, FDAMA, a total revamp of that agency. FDAMA sought to ensure that the FDA had the tools it needed to keep pace with modern scientific advances. We modernized the agency in a way that supported regulating in the least burdensome manner, while ensuring that innovative products would reach patients in as timely a manner as possible. As many of my colleagues remember, these reforms were adopted at a critical point in the fight against the HIV/AIDS epidemic.…





